Incorporation of lycopene into chylomicron remnant-like particles inhibits their uptake by HepG2 cells

Life Sciences

Volumn 80, Issue 18, 2007, Pages 1699-1705

  Bejta, Fatos ^b   Napolitano, Mariarosaria ^a   Botham, Kathleen M ^b   Bravo, Elena ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b ROYAL VETERINARY COLLEGE   (United Kingdom)

Author keywords

Chylomicron remnants; Dietary fat; HepG2 cells; LDL receptor; LDL receptor related protein; Lycopene

Indexed keywords

CHYLOMICRON; HEPARIN LYASE; LOW DENSITY LIPOPROTEIN; LYCOPENE; RADIOISOTOPE; SURAMIN; TRITIUM TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANALYTIC METHOD; ARTICLE; CELL CULTURE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; HEPATOMA CELL; HUMAN; HUMAN CELL; ISOTOPE LABELING; LIVER CELL; RADIOACTIVITY;

ANTINEMATODAL AGENTS; ANTIOXIDANTS; CAROTENOIDS; CELL LINE, TUMOR; CHYLOMICRON REMNANTS; DOSE-RESPONSE RELATIONSHIP, DRUG; HEPARIN LYASE; HEPATOCYTES; HUMANS; LIPOPROTEINS, LDL; RECEPTORS, LDL; SURAMIN;

LYCOPERSICON ESCULENTUM;

EID: 33947301641     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2007.01.051     Document Type: Article

References (38)

1. Albertini R., Moratti R., and DeLuca G. Oxidation of low-density lipoprotein in atherosclerosis from basic biochemistry to clinical studies. Current Molecular Medicine 2 (2002) 579-592
2. Allen C.M., Schwarz S.J., Craft N.E., Giovannucci E.L., De Groff V.L., and Clinton S.K. Changes in plasma and oral mucosal lycopene isomer concentrations in healthy adults consuming standard servings of processed tomato products. Nutrition and Cancer 47 (2003) 48-56
3. Batt K.V., Avella M., Moore E.H., Jackson B., Suckling K.E., and Botham K.M. Differential effects of low density lipoprotein and chylomicron remnants on lipid accumulation in human macrophages. Experimental Biology and Medicine 229 (2004) 528-537
4. Benlian P., De Gennes P.L., Foubert L., Zhang H., Gagne S.E., and Hayden M. Premature atherosclerosis in patients with familial chylomicronemia caused by mutations in the lipoprotein lipase gene. New England Journal of Medicine 335 (1996) 848-854
5. Bjorkegren J., Karpe F., Milne R.W., and Hamsten A. Differences in apolipoprotein and lipid composition between human chylomicron remnants and very low density lipoproteins isolated from fasting and postprandial plasma. Journal of Lipid Research 39 (1998) 1412-1420
6. Botham K.M., Bravo E., Elliott J., and Wheeler-Jones C.P.D. Direct interaction of dietary lipids carried in chylomicron remnants with cells of the artery wall: implications for atherosclerosis development. Current Pharmaceutical Design 11 (2005) 3681-3695
7. Bradford M. A sensitive method for quantitation of microgram quantities of protein utilizing the principle of dye-binding. Analytical Biochemistry 72 (1976) 248-252
8. Clarke R., and Armitage J. Antioxidant vitamins and risk of cardiovascular disease. Review of large scale randomised trials. Cardiovascular Drugs and Therapy 16 (2002) 411-415
9. Deng J., Rudick V., Rudick M., and Dory L. Investigation of plasma membrane-associated apolipoprotein E in primary macrophages. Journal of Lipid Research 38 (1997) 217-227
10. Diard P., Malewiak M.-I., Lagrange D., and Griglio S. Hepatic lipase may act as a ligand in the uptake of artificial chylomicron remnant-like particles by isolated rat hepatocytes. Biochemical Journal 299 (1994) 889-894
11. Goulter A.B., Avella M.A., Elliott J., and Botham K.M. Chylomicron remnant-like particles inhibit receptor-mediated endothelium-dependent vasorelaxation in porcine coronary arteries. Clinical Science 103 (2002) 450-460 (London)
12. Grieve D.J., Avella M.A., Elliott J., and Botham K.M. Influence of chylomicron remnants on endothelial cell function in the isolated perfused rat aorta. Atherosclerosis 139 (1998) 273-281
13. Groot P.H.E., van Stiphout W.A.H., Krauss X.H., Jansen H., van Tol A., van Ramshorst E., Chin-On S., Hofmann A., Cresswell S.R., and Havekes L. Postprandial lipoprotein metabolism in normolipidemic men with and without coronary heart disease. Arteriosclerosis and Thrombosis 11 (1991) 653-662
14. Herz J., Qiu S.-Q., Oesterle H., DeSilva V., Shafi S., and Havel R.J. Initial hepatic removal of chylomicron remnants is unaffected but endocytosis is delayed in mice lacking the low density lipoprotein receptor. Proceedings of the National Academy of Sciences of the United States of America 92 (1995) 4611-4615
15. Ji Z.-S., Fazio S., Lee Y.L., and Mahley R.W. Secretion-capture role for apolipoprotein E in remnant lipoprotein metabolism involving cell surface heparan sulfate proteoglycans. Journal of Biological Chemistry 269 (1993) 2674-2772
16. Ji Z.-S., Dichek H.L., Miranda R.D., and Mahley R.W. Heparan sulfate proteoglycans participate in hepatic lipase and apolipoprotein E-mediated binding and uptake of plasma lipoproteins, including high density lipoproteins. Journal of Biological Chemistry 272 (1997) 31285-31292
17. Kaliora A.C., Dedoussis G.V., and Schmidt H. Dietary antioxidants in preventing atherosclerosis. Atherosclerosis 187 (2005) 1-17
18. Libby P., Geng Y.J., Aikawa M., Schoenbeck U., Mach F., Clinton S.K., Sukhova G.K., and Lee R.T. Macrophages and atherosclerotic plaque stability. Current Opinion in Lipidology 7 (1996) 330-335
19. Mahley R.W., and Ji Z.-S. Remnant lipoprotein metabolism: key pathway involving cell surface heparan sulfate proteoglycans and apolipoprotein E. Journal of Lipid Research 40 (1999) 1-16
20. Moore E.H., Napolitano M., Prosperi A., Avella M., Suckling K.E., Bravo E., and Botham K.M. Incorporation of lycopene into chylomicron remnant-like particles enhances their induction of lipid accumulation in macrophages. Biochemical and Biophysical Research Communications 312 (2003) 1216-1219
21. Moore E.H., Napolitano M., Avella M., Bejta F., Suckling K.E., Bravo E., and Botham K.M. Protection of chylomicron remnants from oxidation by incorporation of probucol into the particles enhances their uptake by human macrophages and increases lipid accumulation in the cells. European Journal of Biochemistry 271 (2004) 2417-2427
22. Napolitano M., and Bravo E. Activation of protein kinase C by phorbol esters in human macrophages reduces the metabolism of modified LDL by down-regulation of scavenger receptor activity. International Journal of Biochemistry and Cell Biology 35 (2003) 1127-1143
23. Paetau I., Khachik F., Brown E.D., Beecher G.R., Kramer T.R., Chittams J., and Clevidence B.A. Chronic ingestion of lycopene-rich tomato juice or lycopene supplements significantly increases plasma concentrations of lycopene and related tomato carotenoids in humans. American Journal of Clinical Nutrition 68 (1998) 1187-1195
24. Pal S., Elsegood C.L., Proctor S.D., and Mamo J.C. Detection of LDL receptor by ligand blotting with chylomicron remnants labelled with colloidal gold. Annals of Clinical Biochemistry 37 (2000) 471-478
25. Pal S., Semorine K., Watts G.F., and Mamo J. Identification of lipoproteins of intestinal origin in human atherosclerotic plaque. Clinical Chemistry and Laboratory Medicine 41 (2003) 792-795
26. Proctor S.D., Vine D.F., and Mamo J.C.L. Arterial retention of apolipoprotein B48- and B100-containing lipoproteins in atherosclerosis. Current Opinion in Lipidology 13 (2002) 461-470
27. Rao A.V. Lycopene, tomatoes and the prevention of coronary heart disease. Experimental Biology and Medicine 227 (2002) 908-913
28. Rapp J.H., Lespine A., Hamilton R.L., Colyvas N., Chaumeton A.H., Tweedie-Harman J., Kotite L., Kunitake S.T., Havel R.J., and Kane J.P. Triglyceride-rich lipoproteins isolated by selective affinity anti-apolipoprotein B immunosorption from human atherosclerotic plaque. Arteriosclerosis and Thrombosis 14 (1994) 1767-1774
29. Redgrave T.G. Formation and metabolism of chylomicrons. International Review of Physiology 28 (1983) 103-130
30. Redgrave T.G., Fidge N.H., and Yin J. Specific, saturable binding and uptake of rat chylomicron remnants by rat skin fibroblasts. Journal of Lipid Research 23 (1982) 638-644
31. Redgrave T.G., Ly H.L., Quintao C.R., Ramberg C.F., and Boston R. Clearance from plasma of triacylglycerol and cholesteryl ester after intravenous injection of chylomicron-like lipid emulsions in rats and man. Biochemical Journal 290 (1993) 843-847
32. Rohlmann A., Gotthardt M., Hammer R.E., and Herz J. Inducible inactivation of hepatic LRP gene by cre-mediated recombination confirms role of LRP in clearance of chylomicron remnants. Journal of Clinical Investigation 101 (1998) 689-695
33. Trichopoulou A., and Vasilopoulou E. Mediterranean diet and longevity. British Journal of Nutrition 84 (2000) 205-209
34. Vassiliou G. Pharmacological concentrations of suramin inhibit the binding of α-2 macroglobulin to its cell surface receptor. European Journal of Biochemistry 250 (1997) 320-325
35. Yu K.C., and Cooper A.D. Postprandial lipoproteins and atherosclerosis. Frontiers in Bioscience 6 (2001) D332-D354
36. Yusuf S., Reddy S., Ounpuu S., and Anand S. Global burden of cardiovascular diseases. Circulation 104 (2001) 2746-2753
37. 14C]-lycopene in rats pre-fed either a control or lycopene-enriched diet. Journal of Nutrition 135 (2005) 2212-2218
38. Zeng B.J., Mortimer B.C., Martins I.J., Seydel U., and Redgrave T.G. Chylomicron remnant uptake is regulated by the expression and function of heparan sulfate proteoglycan in hepatocytes. Journal of Lipid Research 39 (1998) 845-860